New Enterprise Associates
http://www.nea.com/Home/New Enterprise Associates is a venture capital firm based in Baltimore, MD. The firm has backed more than 160 companies that have gone public and invested in more than 230 companies that have been successfully merged or acquired. NEA focuses its investments in the information technology, healthcare, and energy technology industries. While NEA makes a majority of its investments in the United States, the firm invests around the world in China and India. The firm was founded in 1978.
View Older Stories View More Recent Stories
-
OmniSci Shortlisted for 2020 SaaS Awards
-
Topia Announces Topia Compass, Delivering Business Travel and Distributed Workforce Compliance Management
-
Pancreatic Cancer Action Network Appoints New Leadership And Members To Its Board Of Directors
-
New Survey on Pandemic’s Effects Reveals Mixed State of Mind for Essential Workers, Boomers and Millennials
-
New Survey on Pandemic’s Effects Reveals Mixed State of Mind for Essential Workers, Boomers and Millennials
-
USIJ Releases Report on The Importance of an Effective and Reliable Patent System to Critical Technologies
-
Form SC 13D/A GENOCEA BIOSCIENCES, Filed by: New Enterprise Associates 16, L.P.
-
Entel Chooses OmniSci to Improve Customer Satisfaction By Extending Best-in-Class Mobile Operations
-
The Lancet Rheumatology Publishes Clinical Trial Data Demonstrating Promising Safety and Efficacy Profile for a Novel Bioelectronic Device in Patients with Drug Refractory Rheumatoid Arthritis
-
Eargo Announces $71 Million Series E Financing
-
Lumos Pharma to Report Second Quarter 2020 Financial Results and Host a Conference Call on August 13, 2020
-
Lumos Pharma to Report Second Quarter 2020 Financial Results and Host a Conference Call on August 13, 2020
-
Humana and Strive Health Announce Kidney Disease Care Coordination Services Collaboration In Kentucky and Indiana
-
Lumos Pharma, Inc. (LUMO) Sells Priority Review Voucher (PRV) to Merck at $100M Valuation
-
Lumos Pharma Announces Sale of Priority Review Voucher
-
Lumos Pharma Announces Sale of Priority Review Voucher
-
MBX Biosciences Closes $34.6 Million Series A Financing in Rare Endocrine Diseases
-
Form 3 Inozyme Pharma, Inc. For: Jul 23 Filed by: New Enterprise Associates 15, L.P.
-
Form SC 13D Nkarta, Inc. Filed by: New Enterprise Associates 15, L.P.
-
Raise Marketplace LLC Launches Slide Mobile Payments App for Consumers to Earn Unlimited 4% Cash Back at Retail Locations Nationwide
-
Beyond Identity Joins Ping Identity’s Technology Alliance Program to Enable Passwordless Single Sign-On
-
DataRobot Extends Pro Bono AI Platform Licenses to Nonprofit and Social Good Organizations
-
Beyond Identity Joins Ping Identity’s Technology Alliance Program to Enable Passwordless Single Sign-On
-
Form SC 13D Inventiva S.A. Filed by: New Enterprise Associates 17, L.P.
-
Parity.org Launches ParityPledge in Support of People of Color
-
Verona Pharma plc (VRNA) Raises $200 Million in Oversubscribed Private Placement and Subscription
-
Verona Pharma Raises $200 Million in Oversubscribed Private Placement and Subscription
-
Verona Pharma Raises $200 Million in Oversubscribed Private Placement and Subscription
-
Coursera 2020 Global Skills Index Highlights Urgent Need for Reskilling
-
New Survey Reveals Only 17% of Employees Give Their Company an Exceptional Employee Experience Rating
-
Complander Launches Product to Help Reduce Pay Inequity
-
Inventiva announces the pricing of its initial public offering on the Nasdaq Global Market
-
Inventiva announces the pricing of its initial public offering on the Nasdaq Global Market
-
Form 3 Nkarta, Inc. For: Jul 09 Filed by: New Enterprise Associates 15, L.P.
-
Aetion and Cegedim Health Data announce new partnership to power real-world evidence research in Europe
-
Aetion and Cegedim Health Data announce new partnership to power real-world evidence research in Europe
-
Form SC 13D/A Liquidia Technologies Filed by: New Enterprise Associates 12, Limited Partnership
-
Form SC 13D Akouos, Inc. Filed by: New Enterprise Associates 16, L.P.
-
Beyond Identity Joins FIDO Alliance
-
Beyond Identity Joins FIDO Alliance
-
CVRx® Raises $50 Million in New Equity Financing
-
OmniSci Powers New Website Enabling Public to View House-by-House Information On Flint Water Crisis
-
Annexon Closes $100 Million Financing to Advance Broad Pipeline of Classical Complement Therapeutics
-
Annexon Closes $100 Million Financing to Advance Broad Pipeline of Classical Complement Therapeutics
-
Jeff Immelt, Former CEO of GE, Joins Built Robotics as an Advisor
-
Location Technology Company InMarket Selects OmniSci To Provide Accelerated Geospatial Analytics for Marketing Clients
-
Duolingo Names Sara Clemens and Amy Bohutinsky to Board of Directors
-
OmniSci Marks Membership in TM Forum, Showcases Early Results with Telecom Industry Leaders Around 5G Business Resiliency
-
OmniSci Marks Membership in TM Forum, Showcases Early Results with Telecom Industry Leaders Around 5G Business Resiliency
-
DataRobot Expands Partnership with Snowflake, Joins Snowflake Partner Connect

